Serum TGFβ as a predictive biomarker for severe disease and fatality of COVID-19
Description
For targeted intervention in COVID-19, there is a high medical need for biomarkers that predict disease progression and severity in the first days after symptom onset. This study assessed the utility of early transforming growth factor β (TGFβ) serum
